SCHEMBL9038758

SCHEMBL9038758

Cn1ccn(-c2ccc(N3CCN(c4ccc(O)cc4)CC3)cc2)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 3/20 0.48
LMNA P02545 3/20 0.48
GAA P10253 3/20 0.48
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PKM P14618 1/20 0.47
TDP1 Q9NUW8 2/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DRD4 P21917 1/20 0.40
ME2 P23368 6/20 0.39
ME1 P48163 6/20 0.39
ME3 Q16798 6/20 0.39
HTR7 P34969 1/20 0.39
TYR P14679 1/20 0.39
JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12362740 0.90 TDP1 (0.41) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL9041528 0.81 DRD2 (0.51) MAPTALDH1A1LMNAGAASMN1; SMN2
SCHEMBL27545139 0.80 MAPT (0.55) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL11070043 0.75 MAPT (0.62) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL7041242 0.74 MAPT (0.68) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL17664675 0.73 RGS4 (0.47) KDM4EALDH1A1LMNASMN1; SMN2PKM
SCHEMBL526167 0.73 ALDH1A1 (0.63) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL22349820 0.72 GSK3A (0.44) KDM4EHTTSMN1; SMN2MEN1KMT2A
SCHEMBL7133435 0.71 GSK3A (0.48) KDM4EALDH1A1LMNASMN1; SMN2PKM
SCHEMBL9665027 0.70 MAPT (0.62) MAPTKDM4EALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402989-B1 Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones JANSSEN PHARMACEUTICA NV (BE) 1996-04-03 EP disclosed
US-5075309-A For prevention and treatment of fungal diseases in mammals JANSSEN PHARMACEUTICA N.V. (BE) 1991-12-24 US disclosed
EP-0402989-A2 Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones JANSSEN PHARMACEUTICA N.V. (BE) 1990-12-19 EP disclosed